Literature DB >> 2551819

Susceptibility to a mouse acquired immunodeficiency syndrome is influenced by the H-2.

D Hamelin-Bourassa1, E Skamene, F Gervais.   

Abstract

The development of a mouse acquired immunodeficiency syndrome (MAIDS) induced following LP-BM5 MuLV infection depends on host genetic factors. Susceptible mice, such as C57BL/6J mice, develop a profound impairment of lymphoproliferative response to mitogens and hyperplasia of lymphoid organs and succumb to infection within 6 months. These changes do not occur in resistant mice, such as A/J mice. Resistance to MAIDS is a dominant trait since (C57BL/6J x A/J)F1 hybrid mice did not develop any immune dysfunctions following infection. Genetic regulation of the trait of resistance/susceptibility to MAIDS was determined in AXB/BXA recombinant inbred (RI) mouse strains (derived from resistant A/J and susceptible C57BL/6J progenitors). Two different criteria were used to determine their resistance or susceptibility to developing MAIDS: the gross pathologic evaluation of lymphoid organs at 13-15 weeks of infection, and survival. RI mouse strains segregated into two non-overlapping groups. The first group did not develop any significant pathology, and these mouse strains were considered as resistant to MAIDS. The second group showed the virus-induced pathological changes as well as an immunological dysfunction as seen in C57BL/6J progenitor mice, and these strains were thus considered as susceptible to MAIDS. This bimodal strain distribution pattern of resistance/susceptibility to MAIDS among the RI strains suggests that this phenotype is controlled by a single gene. Linkage analysis with other allelic markers showed a strong association between resistance/susceptibility to MAIDS and the H-2 complex. Possession of the H-2b haplotype derived from C57BL/6J mice was associated with susceptibility to MAIDS, while the H-2a haplotype conferred resistance to the disease. This finding was confirmed by demonstrating that H-2a congenics on the susceptible C57BL/10 background were as resistant to MAIDS as A/J mice which donated the H-2a locus. Gene(s) within the H-2 complex thus represent the major regulatory mechanism of resistance/susceptibility to MAIDS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551819     DOI: 10.1007/BF02421330

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  33 in total

Review 1.  Animal models for retrovirus-induced immunodeficiency disease.

Authors:  D E Mosier
Journal:  Immunol Invest       Date:  1986-05       Impact factor: 3.657

Review 2.  The occurrence of malignant tumors in immunosuppressed states.

Authors:  I Penn
Journal:  Prog Allergy       Date:  1986

Review 3.  NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations.

Authors:  A S Fauci; A M Macher; D L Longo; H C Lane; A H Rook; H Masur; E P Gelmann
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

4.  Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses.

Authors:  R M Buller; R A Yetter; T N Fredrickson; H C Morse
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

5.  Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T- but not late B-cell lymphomas.

Authors:  W L Vasmel; M Zijlstra; T Radaszkiewicz; C J Leupers; R E de Goede; C J Melief
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  Genetic control of sensitivity to Moloney-virus-induced leukemias in mice. I. Demonstration of multigenic control.

Authors:  S Gisselbrecht; F Pozo; P Debré; M A Hurot; M J Lacombe; J P Levy
Journal:  Int J Cancer       Date:  1978-05-15       Impact factor: 7.396

7.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

8.  Immune response genes control T killer cell response against Moloney tumor antigen cytolysis regulating reactions against the best available H-2 + viral antigen association.

Authors:  E Gomard; Y Hénin; M J Colombani; J P Lévy
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

9.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.

Authors:  D E Mosier; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

10.  H-2D control of recovery from Friend virus leukemia: H-2D region influences the kinetics of the T lymphocyte response to Friend virus.

Authors:  W J Britt; B Chesebro
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  12 in total

1.  Effects of non-MHC loci on resistance to retrovirus-induced immunodeficiency in mice.

Authors:  M Makino; W F Davidson; T N Fredrickson; J W Hartley; H C Morse
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice.

Authors:  S K Chattopadhyay; D N Sengupta; T N Fredrickson; H C Morse; J W Hartley
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Control of immunodeficiency and lymphoproliferation in mouse AIDS: studies of mice deficient in CD8+ T cells or perforin.

Authors:  Y Tang; A W Hügin; N A Giese; L Gabriele; S K Chattopadhyay; T N Fredrickson; D Kägi; J W Hartley; H C Morse
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Cytolytic T lymphocytes specific for tumors and infected cells from mice with a retrovirus-induced immunodeficiency syndrome.

Authors:  J G Erbe; K A Green; K M Crassi; H C Morse; W R Green
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Alpha/beta interferons increase host resistance to murine AIDS.

Authors:  J K Heng; P Price; C M Lai; M W Beilharz
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency.

Authors:  W R Green; K A Green; K M Crassi
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice.

Authors:  A S Apt; V G Avdienko; B V Nikonenko; I B Kramnik; A M Moroz; E Skamene
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

8.  MAIDS resistance-associated gene expression patterns in secondary lymphoid organs.

Authors:  Suprawee Tepsuporn; Jedediah N Horwitt; George W Cobb; Sharon A Stranford
Journal:  Immunogenetics       Date:  2008-07-09       Impact factor: 2.846

9.  Dissociation between lymphoproliferative responses and virus replication in mice with different sensitivities to retrovirus-induced immunodeficiency.

Authors:  J M Pozsgay; S Reid; P M Pitha
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Susceptibility of inbred strains of mice to murine AIDS (MAIDS) correlates with target cell expansion and high expression of defective MAIDS virus.

Authors:  M Huang; C Simard; P Jolicoeur
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.